Literature DB >> 9721870

Mechanisms of Taxol-induced cell death are concentration dependent.

K Torres1, S B Horwitz.   

Abstract

Although the ability of Taxol to stabilize cellular microtubules is well accepted, the mechanisms by which Taxol induces growth arrest and cell death remain unclear. Recent evidence indicates that Taxol alters specific intracellular signal transduction events, such as the activation of Raf-1 kinase, that may be essential for drug-induced apoptosis. To determine whether Raf-1 kinase activation occurs at different concentrations of Taxol and in response to disruption of the normal microtubule cytoskeleton, A549 cells were treated with different concentrations of Taxol after which Raf-1 activation and the microtubule cytoskeleton were analyzed. Raf-1 activation was observed at Taxol concentrations of 9 nM and greater. However, disruption of the normal microtubule cytoskeleton was seen at lower Taxol concentrations (1-7 nM), indicating that this process begins in the absence of Raf-1 activation. Raf-1 activation correlated with the induction of a G2-M block. Depletion of Raf-1 resulted in the accumulation of cells in the G2-M phase of the cell cycle, suggesting that Raf-1 may play an important role in the passage through mitosis. Supporting this idea, Raf-1 was activated in mitotic cells. Low concentrations of Taxol induced cell death in the absence of Raf-1 activation, indicating that Taxol-induced cell death is not dependent on Raf-1 activation. At concentrations of drug lower than the critical concentration required for Raf-1 activation, p53 and p21(WAF-1) were induced independently of Raf-1. These studies suggest that Taxol-mediated cell death may result from two different mechanisms. At low Taxol concentrations (< 9 nM), cell death may occur after an aberrant mitosis by a Raf-1 independent pathway, whereas at higher Taxol concentrations (> or = 9 nM) cell death may be the result of a terminal mitotic arrest occurring by a Raf-1-dependent pathway.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9721870

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  93 in total

Review 1.  Mechanisms of Taxol resistance related to microtubules.

Authors:  George A Orr; Pascal Verdier-Pinard; Hayley McDaid; Susan Band Horwitz
Journal:  Oncogene       Date:  2003-10-20       Impact factor: 9.867

2.  G(1) and G(2) cell-cycle arrest following microtubule depolymerization in human breast cancer cells.

Authors:  April L Blajeski; Vy A Phan; Timothy J Kottke; Scott H Kaufmann
Journal:  J Clin Invest       Date:  2002-07       Impact factor: 14.808

3.  Effects of griseofulvin on apoptosis through caspase-3- and caspase-9-dependent pathways in K562 leukemia cells: An in vitro study.

Authors:  Ning Zhong; Hankui Chen; Quanlin Zhao; Hongwei Wang; Xin Yu; Ashley M Eaves; Weihua Sheng; Jingcheng Miao; Fengmei Cui; Jinzhi Wang
Journal:  Curr Ther Res Clin Exp       Date:  2010-12

Review 4.  Endophytic Microbial Diversity: A New Hope for the Production of Novel Anti-tumor and Anti-HIV Agents as Future Therapeutics.

Authors:  Aditya Banyal; Vikram Thakur; Rahul Thakur; Pradeep Kumar
Journal:  Curr Microbiol       Date:  2021-03-16       Impact factor: 2.188

5.  Quinacrine Inhibits Cell Growth and Induces Apoptosis in Human Gastric Cancer Cell Line SGC-7901.

Authors:  Xiaoyang Wu; Yunliang Wang; Hongwei Wang; Qiang Wang; Lin Wang; Jingcheng Miao; Fengmei Cui; Jinzhi Wang
Journal:  Curr Ther Res Clin Exp       Date:  2012-02

6.  Growth-inhibiting effects of taxol on human liver cancer in vitro and in nude mice.

Authors:  Jin-Hui Yuan; Ru-Ping Zhang; Ru-Gang Zhang; Li-Xia Guo; Xing-Wang Wang; Dan Luo; Yong Xie; Hong Xie
Journal:  World J Gastroenterol       Date:  2000-04       Impact factor: 5.742

7.  Comparison of cell death-inducing effect of novel taxane SB-T-1216 and paclitaxel in breast cancer cells.

Authors:  Jan Kovár; Marie Ehrlichová; Barbora Smejkalová; Ilaria Zanardi; Iwao Ojima; Ivan Gut
Journal:  Anticancer Res       Date:  2009-08       Impact factor: 2.480

8.  Cell cycle checkpoint models for cellular pharmacology of paclitaxel and platinum drugs.

Authors:  Ardith W El-Kareh; Rachel E Labes; Timothy W Secomb
Journal:  AAPS J       Date:  2008-02-05       Impact factor: 4.009

9.  Sorafenib combined with gemcitabine in EGFR-TKI-resistant human lung cancer cells.

Authors:  Jing Li; Yue-Yin Pan; Ying Zhang
Journal:  Oncol Lett       Date:  2012-10-09       Impact factor: 2.967

10.  Paclitaxel-induced apoptosis in human ovarian cancer cell line COC1.

Authors:  S Wang; Y Lu; D Ma
Journal:  J Tongji Med Univ       Date:  1999
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.